Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 58 clinical trials
Diagnostic Accuracy of WEARable TECHnology Single-lead ECG in Detecting Cardiac Arrhythmias (WEAR-TECH ECG)

placed on the skin to record the heart's electrical activity. A 12-lead ECG uses 10 sensors and is the gold-standard (best available test) to detect any abnormal heart rhythm disturbances. Until recently

Accepts healthy volunteers
  • 0 views
  • 11 May, 2022
  • 1 location
VaLidation of the Simple Adaptation of the Kardia 6L ECG Recorder to Obtain Chest leAd equivaLents: a Multi-centre International (LOCAL-ECG) Study; on Behalf of the Africa Heart Rhythm Association Investigators (LOCAL-ECG)

, thereby obviating the need for a full 12 lead ECG. This may allow for earlier diagnosis and treatment and has implications in the prevention of infection. The lead author recently published a

Accepts healthy volunteers
  • 0 views
  • 24 Apr, 2022
  • 1 location
enHEART - Exploring Full Content of Optical Signals to Enhance Cardiac Arrhythmia Screening (enHEART)

-based PPG monitor simultaneously with 12-lead ECG and intracardiac electrogram (EGM) signals at the university hospital in Lausanne. Importantly, this study will remain purely observational as it will

12 lead ECG
ventricular extrasystoles
atrial flutter
ventricular tachycardia
arrhythmia
  • 0 views
  • 06 Apr, 2022
  • 1 location
3D Non-invasive Myocardial Electrical Propagation Mapping as a New Tool to Predict Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy (3D-CMH)

signed, Holter ECG, scanner and CardioInsightTM 3D_ECG mapping will be planned in the month following the inclusion. 12-lead ECG, 24h holter ECG, cardiac scanner will be performed as standard procedure

hypertrophy
12 lead ECG
heart disease
cardiac mapping
electrocardiogram
  • 0 views
  • 04 Mar, 2022
  • 1 location
Evaluation of the Effect of Long-term Lipid-lowering Therapy in STEMI Patients With Coronavirus Infection COVID-19 (CONTRAST-3)

> Methods and variables Office blood pressure 12-lead ECG Coronary angiography. Percutaneous coronary intervention Chemistry blood test 2D and 3D

atherosclerosis
depression
troponin
atorvastatin
stemi
  • 0 views
  • 27 May, 2022
  • 1 location
Arrhythmogenic Substrate in Primary Cardiomyopathies and/or Channellopathies

This study assesses the value of arrhythmogenic substrate identification and elimination by catheter ablation to prevent recurrent ventricular arrhythmias and sudden cardiac death in a series of selected patients with primary cardiomyopathy and/or channellopaties with ICD implantation.

cardiomyopathy
fibrillation
catheter ablation
ventricular tachycardia
idiopathic cardiomyopathy
  • 21 views
  • 08 May, 2021
  • 1 location
Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation (RESTORE-1)

This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled clinical study designed to evaluate the efficacy and safety of FlecIH-103 (flecainide acetate inhalation solution) compared with placebo in patients with recent-onset, symptomatic newly diagnosed or paroxysmal AF. Approximately 400 patients are expected to be enrolled in this study. Patients will …

fibrillation
flecainide
cardioversion
  • 0 views
  • 13 May, 2022
  • 1 location
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy (HOPE-3) (HOPE-3)

HOPE-3 is a multi-center, randomized, double-blind, placebo-controlled clinical trial evaluating the safety and efficacy of a cell therapy called CAP-1002 in study participants with Duchenne muscular dystrophy (DMD) and impaired skeletal muscle function. Non-ambulatory and ambulatory boys and young men who meet eligibility criteria will be randomly assigned to receive …

glucocorticoids
respiratory assessment
cell therapy
duchenne muscular dystrophy
  • 0 views
  • 05 Jun, 2022
  • 2 locations
Phase 2 Study of VGT-309 in Lung Cancer

A Phase 2 open label study to evaluate safety and efficacy of VGT-309 to identify cancer in up to 40 subjects undergoing lung cancer surgery.

lung carcinoma
lung cancer
cancer
  • 0 views
  • 14 Jun, 2022
  • 1 location
Bi-ventricular Epicardial Activation in Left Bundle Area Pacing: a Comparison Study (LBBAP)

Study of the ventricular activation patterns during left bundle area pacing and compare it with baseline activation during normal sinus rhythm in patients with and without baseline bundle branch conduction disorder.

  • 0 views
  • 15 Jun, 2022
  • 1 location